LEMAITRE VASCULAR (LMAT) CFO Dorian LeBlanc Receives Award

What Happened

• Dorian Paul LeBlanc, Chief Financial Officer of LEMaitre Vascular, received dividend-equivalent rights (derivative awards) on 2026-09-03: 2.886 rights and 3.674 rights, totaling 6.56 dividend-equivalent units. Each unit is the economic equivalent of one share of the company's common stock. The reported acquisition price is $0 and the filing classifies these as award/grant (code A).

Key Details

• Transaction date: 2026-09-03; Form 4 filed: 2026-09-08 (filed 5 days after the transaction; this appears outside the standard two-business-day Form 4 window).
• Units received: 2.886 (from a 3/10/2025 RSU grant) and 3.674 (from a 12/10/2025 RSU grant) — total 6.56 dividend-equivalent rights.
• Price/value reported: $0 (these are dividend-equivalent rights, not a cash purchase).
• Shares owned after transaction: Not disclosed in the provided filing.
• Notable footnotes: F1 — the 2.886 rights accrued on the 3/10/2025 RSU award and vest proportionately with that award. F2 — the 3.674 rights accrued on the 12/10/2025 RSU award and vest proportionately. Each dividend-equivalent right equals the economic equivalent of one common share.

Context

• These are derivative/dividend-equivalent credits tied to previously granted RSUs; they are not an open-market purchase or sale. Dividend-equivalent rights typically track dividends on underlying RSUs and vest/convert according to the RSU vesting schedule.
• This type of award is routine compensation-related reporting and does not by itself indicate the insider buying or selling stock. The delayed filing may be noted by investors but does not change the nature of the award.